Cargando…
Elevated RGMA Expression Predicts Poor Prognosis in Patients with Glioblastoma
BACKGROUND: Glioblastoma (GBM) is the most aggressive type of human brain tumor with a poor prognosis and a low survival rate. Secreted proteins from tumors are recently considered as important modulators to promote tumorigenesis by communicating with microenvironments. Repulsive guidance molecule A...
Autores principales: | Phan, Thi Le, Kim, Hyun-Jin, Lee, Suk Jun, Choi, Moon-Chang, Kim, Sung-Hak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473061/ https://www.ncbi.nlm.nih.gov/pubmed/34588781 http://dx.doi.org/10.2147/OTT.S317285 |
Ejemplares similares
-
RGMa Regulates Cortical Interneuron Migration and Differentiation
por: O'Leary, Conor, et al.
Publicado: (2013) -
The roles of RGMa-neogenin signaling in inflammation and angiogenesis
por: Fujita, Yuki, et al.
Publicado: (2017) -
Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma
por: Se, Young-Bem, et al.
Publicado: (2017) -
Activated Microglia Inhibit Axonal Growth through RGMa
por: Kitayama, Mari, et al.
Publicado: (2011) -
Elevated XRCC5 expression level can promote temozolomide resistance and predict poor prognosis in glioblastoma
por: Lee, I-Neng, et al.
Publicado: (2021)